Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centreMarco Vincenzo Lenti, Antonio Di Sabatino, Raphael Frondana et al.|Internal and Emergency Medicine|2025Cited by 3
Commentary: Towards multi-targeting approaches in intestinal fibrosis – Emerging clues from prim-O-glucosylcimifuginGiovanni Santacroce, Antonio Di Sabatino, Marco Vincenzo Lenti et al.|Life Sciences|2025Cited by 1
Integrating multi-omics and artificial intelligence in internal medicine: Opportunities for precision careGiovanni Santacroce, Antonio Di Sabatino, Antonio Lo Bello et al.|European Journal of Internal Medicine|2026Cited by 0
Disease clearance in immune-mediated gastrointestinal disorders: A new standard or a semantic trap?Giovanni Santacroce, Antonio Di Sabatino, Marco Vincenzo Lenti et al.|European Journal of Internal Medicine|2026Cited by 0